[Federal Register Volume 69, Number 193 (Wednesday, October 6, 2004)]
[Notices]
[Page 59941]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-22415]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel, Pharmacology.
    Date: October 25-26, 2004.
    Time: 5 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Sheraton Chapel Hill Hotel, One Europe Drive, Chapter 
Hill, NC 27514.
    Contact Person: Shiva P. Singh, PhD, Scientific Review 
Administrator, Office of Scientific Review, National Institute of 
General Medical Sciences, National Institutes of Health, Natcher 
Building, Room 3AN-12C, Bethesda, MD 20892, (301) 594-2272, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: September 29, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-22415 Filed 10-5-04; 8:45 am]
BILLING CODE 4140-01-M